Abbott Laboratories (ABT)
(Delayed Data from NYSE)
$107.59 USD
+0.52 (0.49%)
Updated Apr 23, 2024 04:00 PM ET
After-Market: $107.54 -0.05 (-0.05%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth B Momentum C VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
ABT 107.59 +0.52(0.49%)
Will ABT be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for ABT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ABT
Investors Heavily Search Abbott Laboratories (ABT): Here is What You Need to Know
Q1 Earnings Review
ABT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Markets Try to Shake Off April Blues
Abbott (ABT) Q1 Earnings Beat Estimates, Margins Contract
Abbott (ABT) Reports Q1 Earnings: What Key Metrics Have to Say
Other News for ABT
It's Draft Day: Damar Hamlin Helps Build the Abbott HeartMates Team
Not A Millionaire? No Problem! Here's A 10-Stock Portfolio To Retire Comfortably
3 Best Stocks to Buy Now, 4/23/2024, According to Top AnalystsÂ
Dividend Growth Stars: 7 Stocks With 10-Year Double-Digit Rate Hikes
It’s Draft Day: Damar Hamlin Helps Build the Abbott HeartMates Team